
Ask a doctor about a prescription for APIXABAN NORMOGEN 2.5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Apixaban Normogen 2.5 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Apixaban Normogen contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent the formation of blood clots by blocking Factor Xa, an important component of blood clotting.
Apixaban Normogen is used in adults:
Do not take Apixaban Normogen if
Warnings and precautions
Tell your doctor, pharmacist, or nurse before taking this medicine if you have any of these conditions:
Be careful with Apixaban Normogen
If you need to have surgery or a procedure that may cause bleeding, your doctor will tell you to temporarily stop taking this medicine for a period of time. If you are not sure if a procedure may cause bleeding, ask your doctor.
Children and adolescents
This medicine is not recommended for use in children and adolescents under 18 years of age.
Using Apixaban Normogen with other medicines
Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use other medicines.
Some medicines may increase the effects of Apixaban Normogen and some medicines may decrease its effects. Your doctor will decide if you should be treated with Apixaban Normogen if you are taking these medicines and if you should be kept under closer observation.
The following medicines may increase the effects of Apixaban Normogen and increase the risk of unwanted bleeding:
The following medicines may reduce the ability of Apixaban Normogen to prevent blood clots:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, ask your doctor, pharmacist, or nurse for advice before taking this medicine.
The effects of Apixaban Normogen on pregnancy and the fetus are not known. You should not take this medicine if you are pregnant. Tell your doctor, pharmacist, or nurse immediatelyif you become pregnant while taking this medicine.
It is not known if Apixaban Normogen is excreted in human milk. Ask your doctor or pharmacist before taking this medicine during breastfeeding. They will tell you whether to stop breastfeeding or whether to stop or not start taking this medicine.
Driving and using machines
Apixaban Normogen has no influence on the ability to drive or use machines.
Apixaban Normogen contains lactose (a type of sugar) and sodium
If your doctor has told you that you have an intolerance to certain sugars, talk to them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, ask your doctor, pharmacist, or nurse.
Dosage
Take the tablet with water. Apixaban Normogen can be taken with or without food. Try to take the tablets at the same time each day to achieve a better effect of the treatment.
If you have difficulty swallowing the tablet whole, talk to your doctor about other possible ways to take Apixaban Normogen. The tablet can be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before taking it.
Instructions for crushing:
If necessary, your doctor may also administer the crushed Apixaban Normogen tablet mixed in 60 ml of water or 5% glucose in water through a nasogastric tube.
Take Apixaban Normogen according to the following recommendations:
For preventing the formation of blood clots in hip or knee replacement surgery.
The recommended dose of Apixaban Normogen is one 2.5 mg tablet twice a day. For example, take one tablet in the morning and one in the evening.
You should take the first tablet between 12 and 24 hours after surgery.
If you have had major hipsurgery, you will usually take the tablets for a period of 32 to 38 days.
If you have had major kneesurgery, you will usually take the tablets for a period of 10 to 14 days.
For preventing the formation of a blood clot in the heart in patients with an irregular heartbeat and at least one additional risk factor.
The recommended dose of Apixaban Normogen is one 5 mg tablet twice a day.
The recommended dose is one 2.5 mg tablet twice a day if:
The recommended dose is one tablet twice a day, for example, take one tablet in the morning and one in the evening.
Your doctor will tell you how long you should continue the treatment.
For treating blood clots in the veins of the legs and in the blood vessels of the lungs.
The recommended dose is two 5 mg tabletsof Apixaban Normogen twice a day for the first 7 days, for example, two tablets in the morning and two tablets in the evening.
After 7 days, the recommended dose is one 5 mg tabletof Apixaban Normogen twice a day, for example, one tablet in the morning and one in the evening.
For preventing blood clots from recurring after 6 months of treatment.
The recommended dose is one 2.5 mg tablet of Apixaban Normogen twice a day, for example, one tablet in the morning and one in the evening.
Your doctor will tell you how long you should continue the treatment.
Your doctor may change your anticoagulant treatment as follows:
Stop taking Apixaban Normogen. Start treatment with anticoagulant medicines (e.g., heparin) at the time you would take the next Apixaban Normogen tablet.
Stop taking anticoagulant medicines. Start treatment with Apixaban Normogen at the time you would take the next dose of an anticoagulant medicine, and then continue as usual.
Stop taking the medicine that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to start taking Apixaban Normogen.
If your doctor tells you to start taking a medicine that contains a vitamin K antagonist, continue taking Apixaban Normogen for at least 2 days after your first dose of the medicine that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to stop taking Apixaban Normogen.
Patients undergoing cardioversion
If your heartbeat needs to be restored through a process called cardioversion, take this medicine at the times your doctor tells you to prevent blood clots in the blood vessels of the brain and other blood vessels in the body.
If you take more Apixaban Normogen than you should
Tell your doctor immediatelyif you have taken a higher dose of this medicine than prescribed. Take the package of the medicine to your doctor, even if there are no tablets left.
If you take more Apixaban Normogen than the recommended dose, you may increase the risk of bleeding. If bleeding occurs, surgery, blood transfusions, or other treatments that can reverse the anti-factor Xa activity may be necessary.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Apixaban Normogen
If you are unsure what to do or if you forget to take more than one dose, ask your doctor, pharmacist, or nurse.
If you stop taking Apixaban Normogen
Do not stop taking this medicine without talking to your doctor first, because the risk of developing a blood clot may be higher if you stop the treatment too soon.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Apixabán Normogen can be administered in three different diseases. The known adverse effects and the frequency with which they occur may be different and, therefore, are indicated separately below. For those conditions, the most frequent adverse effect of this medicine is bleeding, which can put the patient's life at risk and requires immediate medical attention.
The following adverse effects have been reported when taking Apixabán Normogen to prevent the formation of blood clots in hip or knee replacement surgeries.
Frequent Adverse Effects (may affect up to 1 in 10 people)
Uncommon Adverse Effects (may affect up to 1 in 100 people)
Rare Adverse Effects (may affect up to 1 in 1,000 people)
Unknown Frequency (cannot be estimated from available data)
The following adverse effects have been reported when taking Apixabán Normogen to prevent the formation of blood clots in the heart in patients with irregular heartbeats and at least one additional risk factor.
Frequent Adverse Effects (may affect up to 1 in 10 people)
Uncommon Adverse Effects (may affect up to 1 in 100 people)
Rare Adverse Effects (may affect up to 1 in 1,000 people)
Very Rare Adverse Effects (may affect up to 1 in 10,000 people)
Unknown Frequency (cannot be estimated from available data)
The following adverse effects have been reported when taking Apixabán Normogen to treat or prevent blood clots from recurring in the veins of the legs and in the blood vessels of the lungs.
Frequent Adverse Effects (may affect up to 1 in 10 people)
Uncommon Adverse Effects (may affect up to 1 in 100 people)
Rare Adverse Effects (may affect up to 1 in 1,000 people)
Bleeding:
Unknown Frequency (cannot be estimated from available data)
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on each blister, after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Apixabán Normogen
Tablet core:anhydrous lactose; microcrystalline cellulose (type 14); microcrystalline cellulose (type 101); sodium croscarmellose; sodium lauryl sulfate; magnesium stearate. See section 2 "Apixabán Normogen contains lactose (a type of sugar) and sodium".
Tablet coating:lactose monohydrate; hypromellose (E464); titanium dioxide (E171); triacetin; yellow iron oxide (E172).
Appearance and Package Contents
The film-coated tablets are yellow and round, with a diameter of 6.0 mm ± 0.2 mm.
They are presented in blisters within cartons containing 20 and 60 film-coated tablets.
Only some pack sizes may be marketed.
Patient Information Card: Information Management
Inside the packaging of Apixabán Normogen, along with the prospectus, you will find a Patient Information Card or your doctor may give you a similar card.
This Patient Information Card includes useful information for you and will alert other doctors that you are being treated with Apixabán Normogen. You must keep this card with you at all times.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Manufacturer
Atlantic Pharma – Produções Farmacêuticas, S.A.
Rua da Tapada Grande, n.º 2
Abrunheira, 2710-089 Sintra
Portugal
This medicine is authorized in the EEA member states under the following names:
Spain, Apixabán Normogen 2.5 mg film-coated tablets EFG
Portugal, Apixabano Normogen
Date of the last revision of this prospectus:
December 2022
Other Sources of Information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for APIXABAN NORMOGEN 2.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.